Neuroblastoma and beta-TC6-cell lines were treated with different concentrations (15–500 μg/mL) of FN-CDs, and cell viability was measured by the MTT-assay after 24 h of incubation (Fig. 9a). Here, FN1 is linked to neuroblastoma.